ARELIVON Trademark

Trademark Overview

On Tuesday, January 11, 2011, a trademark application was filed for ARELIVON with the United States Patent and Trademark Office. The USPTO has given the ARELIVON trademark a serial number of 85214743. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 4, 2014. This trademark is owned by Glaxo Group Limited. The ARELIVON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
arelivon

General Information

Serial Number85214743
Word MarkARELIVON
Filing DateTuesday, January 11, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 4, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 3, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 14, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, August 4, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 4, 2014ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 14, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 13, 2014EXTENSION 5 GRANTED
Wednesday, December 11, 2013EXTENSION 5 FILED
Wednesday, December 11, 2013TEAS EXTENSION RECEIVED
Tuesday, June 25, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 24, 2013EXTENSION 4 GRANTED
Friday, June 21, 2013EXTENSION 4 FILED
Friday, June 21, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 10, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 9, 2013EXTENSION 3 GRANTED
Friday, December 7, 2012EXTENSION 3 FILED
Friday, December 7, 2012TEAS EXTENSION RECEIVED
Tuesday, July 24, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 23, 2012EXTENSION 2 GRANTED
Monday, June 25, 2012EXTENSION 2 FILED
Thursday, July 19, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 25, 2012TEAS EXTENSION RECEIVED
Saturday, December 17, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 15, 2011EXTENSION 1 GRANTED
Thursday, December 15, 2011EXTENSION 1 FILED
Thursday, December 15, 2011TEAS EXTENSION RECEIVED
Thursday, December 15, 2011TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 28, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 3, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 3, 2011PUBLISHED FOR OPPOSITION
Tuesday, March 29, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 28, 2011ASSIGNED TO EXAMINER
Friday, January 14, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 14, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

arelivon pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological